Request Deal Involvement

Jazz Pharmaceuticals completed the acquisition of Chimerix for $935m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Collected Strategies

pr advisors

Collected Strategies

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Centerview Partners

financial advisors

Centerview Partners

Cooley

legal advisors

Cooley

Precision AQ

pr advisors

Precision AQ

Guggenheim Partners

financial advisors

Guggenheim Partners

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Joele Frank

pr advisors

Joele Frank

or

Principals

CHIMERIX

target

CHIMERIX

JAZZ PHARMACEUTICALS

bidder

JAZZ PHARMACEUTICALS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Jazz Pharmaceuticals completed the acquisition of Chimerix for $935m.